eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-EGTX.ST-Egetis Therapeutics AB

Egetis Therapeutics AB EGTX.ST

‎kr‎9.50-0.07(-0.73%)(1D)
• Delayed prices by Nasdaq Nordic • In SEK
Analyst Forecast
Consensus
Moderate Buy
Price Target
33.00
Based on analysts who covered EGTX.ST
Invest in Egetis Therapeutics AB
Today
Create an eToro account to buy EGTX.ST stock on a secure, user-friendly, multi-asset trading platform.
Buy EGTX.ST
Egetis Therapeutics AB EGTX.ST
Buy Egetis Therapeutics AB

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

EGTX.ST Stock Price Chart

‎27.01‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The Egetis Therapeutics AB share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Egetis Therapeutics AB share price today is ‎kr‎9.50, reflecting a ‎-0.73‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of EGTX.ST is ‎kr‎4.45B with an average volume in the last three months of 1.99M. The stock has a P/E ratio of -9.44 and a dividend yield of 0%. With the stock’s beta sitting at 0.26
EGTX.ST Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎kr‎4.45B
Day’s Range
i
Shows the high and low prices of the day.
‎kr‎9.06 - ‎kr‎9.51
52W Range
i
Shows the high and low prices of the last year.
‎kr‎4.23 - ‎kr‎10.12
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.99M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-9.44
Revenue
i
The total income generated by this company’s goods and services last year.
‎kr‎66.1M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎kr‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎kr‎9.57
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎kr‎-1.01
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.26

How can I buy Egetis Therapeutics AB stocks?

To purchase Egetis Therapeutics AB:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Egetis Therapeutics AB (EGTX.ST) page and place an order to buy Egetis Therapeutics AB.
Buy EGTX.ST
Looking for more information? Check out our guide on Academy.
What Is Egetis Therapeutics AB?
Egetis Therapeutics AB is a specialised pharmaceutical company focused on developing and commercialising therapies for rare diseases. Operating out of Sweden, its primary aim is to address significant unmet medical needs for patients worldwide who suffer from these conditions.

Operating within the healthcare sector, Egetis Therapeutics AB focuses on advancing late-stage clinical programmes for novel treatments. Their approach aims to bring these therapies through regulatory pathways with the goal of providing effective and life-changing options for patients affected by rare genetic and metabolic disorders.

Keep up to date on the latest share price changes by adding EGTX.ST stock to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
CEO
Nicklas Westerholm
Employees
42
Founded
2006
HQ
Stockholm, Stockholm, SE
Med TechStockholm
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
How do leverage and margin work? We explain what leverage is and how investors can use margin and leverage to increase their buying power.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Go to the Academy >
Invest in Egetis Therapeutics AB
Today
Create an eToro account to buy EGTX.ST stock on a secure, user-friendly, multi-asset trading platform.
Get Started
Buy Egetis Therapeutics AB

FAQ

The current price of EGTX.ST is ‎kr‎9.50.
The average price target for Egetis Therapeutics AB is ‎kr‎33.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Egetis Therapeutics AB based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Egetis Therapeutics AB is ‎kr‎4.45B
Based on 1 analysts offering recommendations for EGTX.ST in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
Buy EGTX.ST
English (UK)
DeutschFrançaisPolskiPortuguêsDanskSuomi
EspañolРусскийالعربيةNederlandsSvenskaRomânăItaliano
中文繁體中文NorskČeštinaTiếng ViệtΕλληνικά
Scroll to top